HIF1A and breast carcinoma: HIF-1α expression has been implicated as an independent predictor of a poor outcome for breast cancer patients, suggesting that HIF-1α levels in the diagnostic tumor biopsy could be used to identify patients that are at increased risk of developing metastasis.